Dignitana AB (publ) (STO:DIGN)
Sweden
· Delayed Price · Currency is SEK 2.300
-0.010 (-0.43%)
May 9, 2025, 4:40 PM CET
Dignitana AB Revenue
In the year 2024, Dignitana AB had annual revenue of 89.83M SEK with 4.38% growth. Dignitana AB had revenue of 23.97M in the quarter ending December 31, 2024, with 12.72% growth.
Revenue
89.83M
Revenue Growth
+4.38%
P/S Ratio
2.06
Revenue / Employee
3.46M
Employees
26
Market Cap
185.25M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 89.83M | 3.77M | 4.38% |
| Dec 31, 2023 | 86.06M | 12.64M | 17.21% |
| Dec 31, 2022 | 73.43M | 16.35M | 28.65% |
| Dec 31, 2021 | 57.07M | 10.44M | 22.40% |
| Dec 31, 2020 | 46.63M | 5.93M | 14.57% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |